Questions of management of patients with hard-to-treat remitting multiple sclerosis
82 patients diagnosed with remitting multiple sclerosis, (MS) undergoing treatment with fingolimod were followed up for minimum 12 months at the Moscow Multiple Sclerosis Centre. The purpose of the follow-up was to evaluate the effects of fingolimod. 9 of 12 patients were subject to a comprehensive...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Russo |
| Foilsithe / Cruthaithe: |
Remedium Group LLC
2015-12-01
|
| Sraith: | Медицинский совет |
| Ábhair: | |
| Rochtain ar líne: | https://www.med-sovet.pro/jour/article/view/274 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|